Protective effect of Na+ /H+ exchange inhibitor, SM-20550, on impaired mitochondrial respiratory function and mitochondrial Ca2+ overload in ischemic/reperfused rat hearts

Journal of Cardiovascular Pharmacology
Setsuko YamamotoNaohito Ohashi

Abstract

The aim of this study was to investigate whether a selective Na+/H+ exchange inhibitor, SM-20550, can modulate the mitochondrial respiratory function and mitochondrial Ca2+ content in isolated rat hearts subjected to 40 min of ischemia and 20 min of reperfusion. SM-20550 (10, 100 nM) was administered for 5 min prior to ischemia and for 20 min during the reperfusion period. At 20 min after reperfusion, treatment with SM-20550 (10, 100 nM) improved the recovery of left ventricular developed pressure and suppressed the rise in left ventricular end-diastolic pressure. Mitochondrial function, assessed by the state 3 oxygen respiration rate, respiratory control index, and oxidative phosphorylation rate, was significantly impaired after ischemia/reperfusion. Administration with SM-20550 (10, 100 nM) attenuated the impaired mitochondrial function, improving the state 3 respiration rate, respiratory control index, and oxidative phosphorylation rate. The mitochondrial Ca2+ content was significantly increased after ischemia/reperfusion but was suppressed by treatment with SM-20550 (10, 100 nM). A significant linear correlation was observed between the respiratory control index and mitochondrial Ca2+ content in the ischemic/reperfused hear...Continue Reading

References

Aug 1, 1979·Journal of Molecular and Cellular Cardiology·Y EdouteA Lochner
Jan 1, 1990·Annual Review of Physiology·M Tani
Jul 1, 1990·Circulation·D B Pryor
Jan 1, 1994·Cardiovascular Research·H M PiperB Siegmund
Jun 1, 1993·British Journal of Pharmacology·W ScholzB A Schölkens
May 1, 1996·Basic Research in Cardiology·H M PiperD Garcia-Dorado
Oct 1, 1996·Journal of Molecular and Cellular Cardiology·V BorutaiteG C Brown
Apr 4, 1998·Journal of Molecular and Cellular Cardiology·L KayA Rossi
Aug 1, 1998·Naunyn-Schmiedeberg's Archives of Pharmacology·S DheinM Gottwald
Dec 11, 1999·Journal of Molecular and Cellular Cardiology·M Hartmann, U K Decking

❮ Previous
Next ❯

Citations

Feb 21, 2004·European Journal of Pharmacology·He-Ying SunZhi-Qing Zhao
Nov 1, 2008·Critical Care Medicine·Iyad M AyoubRaúl J Gazmuri
Sep 23, 2008·Journal of Cardiovascular Pharmacology·Mohammed AldakkakAmadou K S Camara
Jun 6, 2003·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Kouichi Tanonaka, Satoshi Takeo
Mar 22, 2012·Critical Care Clinics·Raúl J Gazmuri, Jeejabai Radhakrishnan
Jan 25, 2011·Translational Research : the Journal of Laboratory and Clinical Medicine·Jeejabai RadhakrishnanRaúl J Gazmuri
Mar 17, 2009·Journal of Molecular and Cellular Cardiology·Lindsay S BurwellPaul S Brookes
Apr 2, 2004·Pharmacology & Therapeutics·Andreas Goette, Uwe Lendeckel
Jul 19, 2005·Biochemical and Biophysical Research Communications·Koichi UemuraKen-ichi Yoshida
Sep 26, 2013·Biochemical Society Transactions·Marion Babot, Alexander Galkin
Aug 17, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Hema I Gursahani, Saul Schaefer
Oct 2, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Takako TodaHideyuki Ishida
Aug 20, 2005·The Biochemical Journal·Giancarlo Solaini, David A Harris
May 19, 2010·Pharmaceuticals·Yoshihiro SuzukiChisei Ra
Aug 14, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Marisol Ruiz-MeanaJordi Soler-Soler
Jan 22, 2021·Pflügers Archiv : European journal of physiology·Xinyu ZhouJianjie Ma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.